Zen Technologies Q2 FY27 results: what the company reported
Zen Technologies Limited filed its unaudited results for the quarter from July to September 2026 with NSE on 31 October 2026, the day its board approved them.
Published 2 November 2026 · Potoos Research Services
In one line. On a consolidated basis, Zen Technologies reported revenue from operations of ₹34,513.26 lakh for the quarter ended 30 September 2026, against ₹17,357.31 lakh in the same quarter of 2025, and net profit attributable to shareholders of ₹8,954.09 lakh, against ₹5,939.90 lakh.
The numbers, from the filing
These are the consolidated figures from the company's statement of unaudited results. The company also files standalone figures; consolidated figures include its subsidiaries, so we use those here. The filing reports in rupees lakh (100 lakh make 1 crore). The change column is our own arithmetic on the filing's numbers, rounded to one decimal.
Quarter: July to September 2026 (Q2 FY27) against July to September 2025 (Q2 FY26). ₹ lakh, consolidated, unaudited.
| Item | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 34,513.26 | 17,357.31 | +98.8% |
| Total income | 36,184.50 | 19,887.98 | +81.9% |
| Net profit for the period | 10,188.33 | 6,190.46 | +64.6% |
| Net profit attributable to shareholders of the company | 8,954.09 | 5,939.90 | +50.7% |
| Earnings per share, basic (₹, not annualised) | 9.97 | 6.61 | +50.8% |
Half year: April to September 2026 (H1 FY27) against April to September 2025 (H1 FY26). ₹ lakh, consolidated, unaudited.
| Item | H1 FY27 | H1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 48,677.10 | 33,179.18 | +46.7% |
| Total income | 52,263.98 | 37,888.89 | +37.9% |
| Net profit for the period | 13,373.27 | 11,497.96 | +16.3% |
| Net profit attributable to shareholders of the company | 12,400.19 | 10,715.16 | +15.7% |
| Earnings per share, basic (₹, not annualised) | 13.80 | 11.92 | +15.8% |
The company's press release gives the same quarter in rupees crore: revenue of ₹345.13 crore and profit after tax, adjusted for non-controlling interest, of ₹89.54 crore. These match the lakh figures above.
What the company said
The lines below are the company's own words, quoted from its press release filed with NSE on 1 November 2026. They are the company's statements, not ours.
“Order inflow during the quarter was ₹481.81 crore, taking the consolidated order book to ₹1,375.70 crore as at 30 September 2026.”
Zen Technologies press release, 1 November 2026
“Zen has begun delivering the Fast Track Procurement orders received last year, ahead of the contractual timelines.”
Ashok Atluri, Chairman and Managing Director, in the same press release
“That is possible because the technology is ours - there is no foreign licensor to go back to when the Army changes a requirement, so the product changes in weeks, not procurement cycles.”
Ashok Atluri, Chairman and Managing Director, in the same press release
Dates
- Board meeting: Saturday, 31 October 2026. The filing says it began at 11:30 a.m. and ended at 04.18 p.m. (IST).
- Results filed with NSE: 31 October 2026.
- Press release filed: 1 November 2026.
- Also approved at the same meeting: voluntary strike-off of Zen Medical Technologies Private Limited, a wholly owned subsidiary, subject to the approval of the relevant regulatory authorities.
Consolidated results add up the parent company and the companies it controls, as if they were one business. Standalone results cover the parent company alone.
EPS (earnings per share) is the profit belonging to shareholders divided by the number of shares. “Not annualised” means it is for that quarter or half year only, not a full-year figure.
Source
- Outcome of board meeting with unaudited results, filed on NSE, 31 October 2026: nsearchives.nseindia.com/corporate/ZENTEC_31102026162542_BM_OC_UFR_Q2FY26.pdf (the file name says Q2FY26; the document covers the period ended 30 September 2026)
- Press release, filed on NSE, 1 November 2026: nsearchives.nseindia.com/corporate/ZENTEC_01112026184856_SEPR30092026.pdf
This page reports what the company filed. It is not a recommendation to buy, sell or hold.
